UBS’s ROCHESTER MEDICAL CORP ROCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-12,636
Closed -$252K 11308
2013
Q3
$252K Buy
12,636
+9,975
+375% +$163K ﹤0.01% 4899
2013
Q2
$39K Buy
+2,661
New +$38K ﹤0.01% 7067

UBS's ROCM Position: Q4 2013 in Review

UBS sold out of ROCHESTER MEDICAL CORP (ROCM) in Q4 2013, closing a stake of 12,636 shares — an estimated $252K sold.

UBS first reported a position in ROCM in Q2 2013 and held it in 2 quarters. The position peaked at $252K in Q3 2013. 0 funds tracked by Wall St. Rank hold ROCM as of Q4 2013.

  • UBS reported no remaining ROCHESTER MEDICAL CORP position as of Q4 2013 after selling out during the quarter.
  • UBS sold 12,636 ROCHESTER MEDICAL CORP shares in Q4 2013, an estimated $252K.
  • UBS first reported a position in ROCHESTER MEDICAL CORP in Q2 2013 and held it in 2 quarters.
  • UBS's ROCHESTER MEDICAL CORP position peaked at $252K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ROCHESTER MEDICAL CORP as of Q4 2013.

Based on UBS's 13F filing for Q4 2013, filed 14 Feb 2014.